Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria

Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015 · see citing works

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV

Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561 · see citing works

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523 · see citing works

Cerebral Hemorrhage After Passive Anti-Aβ Immunotherapy

Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufenbiel, M., Mathews, P. M., & Jucker, M. (2002) · Science · doi:10.1126/science.1078259 · Cited by 511 · see citing works

Exercitatio anatomica de motv cordis et sangvinis in animalibvs

Harvey, W., De Landau, H., & Library, B. (1628) · doi:10.5479/sil.126677.39088002685501 · Cited by 420 · see citing works

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar, D. R., Cohen, D., Hedera, P., Friedland, R. P., & Kalaria, R. N. (1996) · Europe PMC (PubMed Central) · Cited by 345 · see citing works

Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study

Pfeifer, L. A., White, L. R., Ross, G. W., Petrovitch, H., & Launer, L. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1629 · Cited by 338 · see citing works

Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

Winkler, D. T., Bondolfi, L., Herzig, M. C., Jann, L., Calhoun, M. E., Wiederhold, K., Tolnay, M., Staufenbiel, M., & Jucker, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01619.2001 · Cited by 287 · see citing works

Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

Révész, T., Ghiso, J. A., Lashley, T., Plant, G. T., Rostagno, A. A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 286 · see citing works

High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

Nicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Dewar, D., Ironside, J. W., Stewart, J., & Vinters, H. V. (1997) · Annals of Neurology · doi:10.1002/ana.410410607 · Cited by 284 · see citing works

Sporadic and Familial Cerebral Amyloid Angiopathies

Révész, T., Holton, J. L., Lashley, T., Plant, G. T., Rostagno, A. A., Ghiso, J. A., & Frangione, B. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00449.x · Cited by 199 · see citing works

Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain

Smith, M. A., Casadesús, G., Joseph, J. A., & Perry, G. L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01021-3 · Cited by 189 · see citing works

Intracellular APP Processing and Aβ Production in Alzheimer Disease

Wilson, C., Doms, R. W., & Lee, V. M. ‐. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199908000-00001 · Cited by 187 · see citing works

Ueber eine im Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose

Virchow, R. (1854) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01930815 · Cited by 178 · see citing works

Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles

Natté, R., Maat‐Schieman, M. L. C., Haan, J., Bornebroek, M., Roos, R. A. C., & Van Duinen, S. G. (2001) · Annals of Neurology · doi:10.1002/ana.10040 · Cited by 166 · see citing works

Metabolic, Metallic, and Mitotic Sources of Oxidative Stress in Alzheimer Disease

Smith, M. A., Nunomura, A., Zhu, X., Takeda, A., & Perry, G. L. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192198 · Cited by 151 · see citing works

The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological Studies

Hyman, B. T. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00066-3 · Cited by 143 · see citing works

Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies

Cadavid, D., Mena, H., Koeller, K. K., & Frommelt, R. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.768 · Cited by 137 · see citing works

Regional Distribution of Amyloid-Bri Deposition and Its Association with Neurofibrillary Degeneration in Familial British Dementia

Holton, J. L., Ghiso, J. A., Lashley, T., Rostagno, A. A., Guérin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63993-4 · Cited by 131 · see citing works

Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study

Jellinger, K. A., & Attems, J. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0634-5 · Cited by 121 · see citing works

Failure of inactivation of Duchenne dystrophy X‐chromosome in one of female identical twins

Gómez, M. R., Engel, A. G., Dewald, G. W., & Peterson, H. A. (1977) · Neurology · doi:10.1212/wnl.27.6.537 · Cited by 96 · see citing works

Risk Factors for Cerebral Amyloid Angiopathy in the Elderly

Yamada, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04797.x · Cited by 88 · see citing works

Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele

Vidal, R., Calero, M., Piccardo, P., Farlow, M. R., Unverzagt, F. W., Méndez, E., Jiménez‐Huete, A., Beavis, R. C., Gallo, G., Gómez‐Tortosa, E., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010051186 · Cited by 83 · see citing works

Zur Amyloidfrage

Friedreich, N., & Kekulé, A. (1859) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01945246 · Cited by 79 · see citing works

The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old

García‐Sierra, F., Hauw, J. J., Duyckaerts, C. J., Wischik, C. M., Luna‐Muñoz, J., & Mena, R. (2000) · Acta Neuropathologica · doi:10.1007/s004010051189 · Cited by 69 · see citing works

Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.

Perry, G., Smith, M. A., McCann, C., Siedlak, S., Jones, P. K., & Friedland, R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00006-7 · Cited by 69 · see citing works

Analysis of Cerebral Amyloid Angiopathy in a Transgenic Mouse Model of Alzheimer Disease Using In Vivo Multiphoton Microscopy

Kimchi, E. Y., Kajdasz, S. T., Bacskai, B. J., & Hyman, B. T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.274 · Cited by 39 · see citing works

Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders

Verbeek, M., de Waal, R., & Vinters, H. (2000) · Springer Netherlands · doi:10.1007/978-94-017-1007-7 · Cited by 33 · see citing works

Vascular Variant of Alzheimer's Disease Characterized by Severe Plaque-Like β Protein Angiopathy

Yamada, M., Itoh, Y., Suematsu, N., Otomo, E., & Matsushita, M. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106626 · Cited by 23 · see citing works

Impaired Processing of Famous Faces in Alzheimer’s Disease Is Related to Neurofibrillary Tangle Densities in the Prefrontal and Anterior Cingulate Cortex

Giannakopoulos, P., Gold, G., Duc, M., Michel, J., Hof, P. R., & Bouras, C. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017263 · Cited by 22 · see citing works

Clinical Aspects and Diagnostic Criteria of Sporadic CAA-Related Hemorrhage

Greenberg, S. M. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_1 · Cited by 5 · see citing works

Alzheimer Disease

Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 561 · see citing works

Smoking and increased Alzheimer's disease risk: A review of potential mechanisms

Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 461 · see citing works

Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus.

Boekhoorn, K., Joëls, M., & Lucassen, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 342 · see citing works

Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice

Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.-Q., Bien-Ly, N., Puoliväli, J., Scearce-Levie, K., Masliah, E., & Mucke, L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0482-06.2006 · Cited by 254 · see citing works

Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease

TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242 · see citing works

Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice

Merlini, M., Meyer, E. P., Ulmann-Schuler, A., & Nitsch, R. M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0834-y · Cited by 225 · see citing works

Amyloid-Peptide Vaccinations Reduce β-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer’s Transgenic Mice

Liu, B., Rasool, S., Yang, Z., Glabe, C. G., Schreiber, S. S., Ge, J., & Tan, Z. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090159 · Cited by 182 · see citing works

Structure and function of amyloid in Alzheimer's disease

Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 136 · see citing works

Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 133 · see citing works

<i>In Vivo</i> mouse imaging and spectroscopy in drug discovery

Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118 · see citing works

Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease

Bourasset, F., Ouellet, M., Tremblay, C., Julien, C., Minh, T. N., Oddo, S., LaFerla, F. M., & Calon, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.006 · Cited by 105 · see citing works

Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots

Yang, S.-H., Li, W., Sumien, N., Forster, M. J., Simpkins, J. W., & Liu, R. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.005 · Cited by 86 · see citing works

The role of iron as a mediator of oxidative stress in Alzheimer disease

Castellani, R. J., Moreira, P. I., Perry, G. L., & Zhu, X. (2012) · BioFactors · doi:10.1002/biof.1010 · Cited by 82 · see citing works

Cognitive impairment of vascular origin: Neuropathology of cognitive impairment of vascular origin

Ferrer, I. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.039 · Cited by 79 · see citing works

Early Alterations in Functional Connectivity and White Matter Structure in a Transgenic Mouse Model of Cerebral Amyloidosis

Grandjean, J., Schroeter, A., He, P., Tanadini, M., Keist, R., Krstic, D., Konietzko, U., Klohs, J., Nitsch, R. M., & Rudin, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4762-13.2014 · Cited by 70 · see citing works

Ocular manifestations of Alzheimer's disease in animal models

Parnell, M., Guo, L., Abdi, M., & Cordeiro, M. F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/786494 · Cited by 56 · see citing works

Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid

Austin, S. A., & Katusic, Z. S. (2020) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x18822474 · Cited by 52 · see citing works

Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments

Wang, H., Sang, N., Zhang, C. M., Raghupathi, R., Tanzi, R. E., & Saunders, A. J. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00329 · Cited by 48 · see citing works

Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy

Nehls, M. (2016) · Journal of Molecular Psychiatry · doi:10.1186/s40303-016-0018-8 · Cited by 41 · see citing works

Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model

Lifshitz, V., Weiss, R., Benromano, T., Kfir, E., Blumenfeld‐Katzir, T., Tempel-Brami, C., Assaf, Y., Xia, W., Wyss‐Coray, T., Weiner, H. L., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.006 · Cited by 38 · see citing works

Is passive immunization for Alzheimer's disease ‘alive and well’ or ‘dead and buried’?

Jicha, G. A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902828285 · Cited by 37 · see citing works

Vessel ultrastructure in APP23 transgenic mice after passive anti-Aβ immunotherapy and subsequent intracerebral hemorrhage

Burbach, G. J., Vlachos, A., Ghebremedhin, E., Turco, D. D., Coomaraswamy, J., Staufenbiel, M., Jucker, M., & Deller, T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.003 · Cited by 33 · see citing works

Cerebral amyloid angiopathy and Alzheimer’s disease

de Courten‐Myers, G. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.004 · Cited by 32 · see citing works

TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis

Weiss, R., Lifshitz, V., & Frenkel, D. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.11.012 · Cited by 26 · see citing works

Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer’s disease

Zhang, Y., Bander, E. D., Lee, Y., Muoser, C. A., Schaffer, C. B., & Nishimura, N. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19889092 · Cited by 26 · see citing works

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 21 · see citing works

Dementia Associates with Undermedication of Cardiovascular Diseases in the Elderly

Löppönen, M. K., Räihä, I. J., Isoaho, R. E., Vahlberg, T. J., Puolijoki, H., & Kivelä, S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093739 · Cited by 21 · see citing works

Current Clinical Applications of Intracranial Vessel Wall MR Imaging

Mattay, R. R., Saucedo, J. F., Lehman, V. T., Xiao, J., Obusez, E. C., Raymond, S. B., Fan, Z., & Song, J. W. (2021) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2021.07.004 · Cited by 20 · see citing works

Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?

Barger, S. W. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-2 · Cited by 19 · see citing works

Molecular Pathology of Alzheimer's Disease

Castellani, R. J., & Perry, G. L. (2013) · Colloquium Series on Neurobiology of Alzheimer s Disease · doi:10.4199/c00095ed1v01y201310alz001 · Cited by 19 · see citing works

Clinical-pathologic correlations in vascular cognitive impairment and dementia

Flanagan, M. E., Larson, E. B., Latimer, C. S., Cholerton, B., Crane, P. K., Montine, K. S., White, L. R., Keene, C. D., & Montine, T. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.019 · Cited by 17 · see citing works

Non-neuronal and neuronal BACE1 elevation in association with angiopathic and leptomeningeal β-amyloid deposition in the human brain

Xue, Z., He, Z.-W., Yu, J.-J., Cai, Y., Qiu, W.-Y., Pan, A., Gai, W.-P., Cai, H., Luo, X.-G., Ma, C., et al. (2015) · BMC Neurology · doi:10.1186/s12883-015-0327-z · Cited by 16 · see citing works

Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview

Carvalho, C., Correia, S. C., Perry, G. L., Castellani, R. J., & Moreira, P. I. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1367-7 · Cited by 14 · see citing works

Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer’s Disease and the General Population in Australia

Ilomäki, J., Fanning, L., Keen, C., Sluggett, J. K., Page, A. T., Korhonen, M. J., Meretoja, A., Namara, K. M., & Bell, J. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190094 · Cited by 14 · see citing works

Vascular Cognitive Impairment

Srikanth, V. K., Saling, M. M., & Thrift, A. G. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50023-2 · Cited by 9 · see citing works

Evaluating [68Ga]Ga-p14-032 as a Novel PET Tracer for Diagnosis Cerebral Amyloid Angiopathy

Zhang, Q., Zhao, X., Lei, P., Kung, H. F., Yang, Z., Zhu, L., Wang, S., Zhu, H., Meng, X., Duan, Y., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.702185 · Cited by 7 · see citing works

In Vivo Mouse Imaging and Spectroscopy in Drug Discovery

Beckmann, N., Cannet, C., Rausch, M., Kneuer, R., & Gremlich, H. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0134-7_15 · Cited by 6 · see citing works

Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5 · see citing works

Age exacerbates the effect of myopia on retinal capillaries and string vessels

Lin, C. R., Toychiev, A. H., Ablordeppey, R. K., Srinivas, M., & Benavente-Pérez, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1112396 · Cited by 5 · see citing works

Alterations in the inflammatory homeostasis of aging‐related cardiac dysfunction and Alzheimer's diseases

Huang, S., Nunez, J., Toresco, D. L., Wen, C., Slotabec, L. A., Wang, H., Zhang, H., Rouhi, N., Adenawoola, M. I., & Li, J. (2025) · The FASEB Journal · doi:10.1096/fj.202402725rr · Cited by 4 · see citing works

The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response

Bonda, D., Webber, K. M., Siedlak, S. L., Perry, G. L., Friedland, R. P., & Smith, M. A. (2007) · American Journal of Immunology · doi:10.3844/ajisp.2007.10.14 · Cited by 4 · see citing works

Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment: Cerebrospinal Fluid Biomarkers

Rothenberg, K. G., Bekris, L. M., Leverenz, J. B., Wu, J. C. N., Lee, J., Statsevych, V., Ruggieri, P. M., & Jones, S. E. (2024) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000539884 · Cited by 3 · see citing works

Exercise, cognition and dementia

Scherder, E., & Eggermont, L. H. P. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781316529898.019 · Cited by 2 · see citing works

Senile Dementia

Pedersen, W. A. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60662-2 · Cited by 1 · see citing works

Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases

Lanning, J. D., & Meredith, S. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_14 · Cited by 1 · see citing works

Cholesterol Potentiates β-Amyloid Genesis in Cultured Human Umbilical Vein Endothelial Cells

Huang, G.-Z., Xue, Z.-Q., Hu, X., Wan, L., Li, J., Cai, Y., Patrylo, P., Luo, X.-G., Pan, A., & Yan, X.-X. (2016) · Advances in Alzheimer s Disease · doi:10.4236/aad.2016.52002 · Cited by 1 · see citing works

A Brief Introduction to the History of the β-Amyloid Protein (Aβ) of Alzheimer’s Disease

Small, D. H., & Barrow, C. J. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_1

Neurorehabilitation in dementia on the move : Influences of physical activity on cognition, mood, and the rest-activity rhythm

Eggermont, L. H. P. (2007) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)

Observations on cerebral amyloid angiopathy and microvascular pathology in Alzheimer's disease and vascular dementia

Haglund, M. (2005) · Lund University Publications (Lund University)

Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs

Castellani, R. J., Lee, H., Petersen, R. B., Zhu, X., & Perry, G. L. (2011) · Therapy · doi:10.2217/thy.11.62

Cell Cycle Activation and the Amyloid-β Protein in Alzheimer’s Disease

Gustaw, K. A., Casadesús, G., Friedland, R. P., Perry, G. L., & Smith, M. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-021-8_22

Investigating the impact of vascular amyloid plaque deposition in mouse models of Alzheimer’s disease using non-invasive imaging techniques

Princz-Kranz, F. L. (2010) · Zurich Open Repository and Archive (University of Zurich) · doi:10.3929/ethz-a-006097535

Beta Amyloid

Meyer, R. A. (2008) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.63864-4

Dementias☆

Anderson, H. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05297-1

Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer

Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c

Intégrité de la barrière hémato-encéphalique et transport du peptide bêta-amyloïde dans la maladie d'Alzheimer

Do, T. M. (2012) · theses.fr (ABES) · doi:10.70675/39078922z7524z4044z80dcz166165217d2b

Etudes de trois métalloprotéases matricielles, MT1-MMP, MT5-MMP et MMP-12 dans l'amyloïdogenèse et les atteintes inflammatoires et vasculaires associées à la maladie d'Alzheimer

Bonnet, A. (2017) · theses.fr (ABES) · doi:10.70675/7fa1337ez8c86z4faezb643z1ee618bb3cfa

Cerebral Amyloid Angiopathy: Perspectives on Cerebrovascular Dysfunction

Johnson, A. (2013) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000e108 · Cited by 1 · see citing works

＜Symposium IV＞Cerebral amyloid angiopathy and Alzheimer's disease

Ghiso, J. A., Tomidokoro, Y., Revez, T., Frangione, B., & Rostagno, A. A. (2010) · Institutional Repositories DataBase (IRDB)

Cerebral amyloid angiopathy--a disease or age-related condition.

Soffer, D. (2006) · PubMed · Cited by 25 · see citing works

Cerebral amyloid angiopathy and dementia.

Tian, J., Shi, J., & Mann, D. (2004) · PubMed · Cited by 55 · see citing works

Amyloid Angiopathy–Related Vascular Cognitive Impairment

Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298 · see citing works